跳到正文
openFDA 已分级药品召回执法报告·· 12 天前AI 评分57

FDA 召回执法报告 D-0154-2027:Victory Medical Center Pharmacy 替尔泊肽/烟酰胺注射剂因加工控制缺失被列为 II 类召回

FDA drug enforcement D-0154-2027: Victory Medical Center Pharmacy — Lack of Processing Controls

AI 导读

FDA 召回执法报告 D-0154-2027 收录 Victory Medical Center Pharmacy(德州奥斯汀)的替尔泊肽/烟酰胺(MDV)20/2MG/ML 3ML 产品,召回原因为加工控制缺失(Lack of Processing Controls),定为 II 类,由企业自愿发起。

正文 · 原文

FDA drug recall enforcement report — D-0154-2027

Report issued: 2026-11-11. This is the enforcement report date, not the recall initiation date.

Scope: one classified drug product recall record; event_id may group multiple products. Unclassified records without recall numbers are outside this stream. This record is not a press release or a new enforcement finding.

The openFDA dataset is updated weekly. Report status is not a live recall status and must not be used to track the recall lifecycle. Other dates below retain their named meanings.

Complete official product record (including openFDA harmonized identifiers):

{

"address_1": "4303 Victory Dr",

"address_2": "",

"center_classification_date": "20261030",

"city": "Austin",

"classification": "Class II",

"code_info": "Lot, expiry: Lot 2025319 , exp 10/23/2026; Lot 2064762 , exp 11/11/2026; Lot 2049664 , exp 11/19/2026",

"country": "United States",

"distribution_pattern": "CO, FL, TX",

"event_id": "100168",

"initial_firm_notification": "Letter",

"more_code_info": "",

"openfda": {},

"postal_code": "78704-7507",

"product_description": "TIRZEPATIDE/NIACINAMIDE (MDV) 20/2MG/ML **3ML**, VMC, Victory Medical Center Pharmacy, Austin, Texas",

"product_quantity": "208 vials",

"product_type": "Drugs",

"reason_for_recall": "Lack of Processing Controls",

"recall_initiation_date": "20261019",

"recall_number": "D-0154-2027",

"recalling_firm": "Victory Medical Center Pharmacy",

"report_date": "20261111",

"state": "TX",

"status": "Ongoing",

"voluntary_mandated": "Voluntary: Firm initiated"

}

来源:openFDA 已分级药品召回执法报告 · api.fda.gov